Skip to main content
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. — Investor Relations & Filings

Ticker · ENVB ISIN · US02362F3029 US Professional, scientific and technical activities
Open in API
Filings indexed 1,028 across all filing types
Latest filing 2024-10-12 Director's Dealing
Country US United States of America
Listing US ENVB

About Enveric Biosciences, Inc.

https://www.enveric.com/

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Recent filings

Filing Released Lang Actions
Director's Dealing 2024
Director's Dealing
2024-10-12 English
Capital/Financing Update 2024
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to Rule 424(b)(4) related to the offer and resale of common stock by a selling stockholder, Lincoln Park Capital Fund, LLC. It details the terms of a purchase agreement for up to 4,900,000 shares, the registration statement numbers, and the nature of the offering. The document includes sections such as Risk Factors, Use of Proceeds, Selling Stockholder, and Plan of Distribution, which are typical components of a prospectus related to capital raising or resale of shares. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a detailed disclosure document for a securities offering. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document length (15,000 characters) and detailed content confirm it is not a mere announcement but the actual prospectus document.
2024-09-12 English
Regulatory Filings 2024
Regulatory Filings
2024-09-12 English
Capital/Financing Update 2024
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-1. It is a formal communication related to a securities registration process, specifically requesting the SEC to declare the registration statement effective at a certain date and time. The document does not contain financial data, report content, or detailed disclosures but is rather a procedural filing related to capital raising. This fits the category of Capital/Financing Update (CAP), which includes updates on company fundraising and related filings.
2024-09-10 English
Regulatory Filings 2024
Regulatory Filings
2024-09-09 English
Capital/Financing Update 2024
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the offering of common stock, the selling stockholder, the purchase agreement, and related legal and financial disclosures. This type of filing is related to capital raising activities and financing updates rather than financial performance reports, management changes, or other categories. Therefore, it fits the Capital/Financing Update (CAP) category. The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Confidence is high given the clear identification of the form and content.
2024-09-05 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.